E2f1 (E2F transcription factor 1) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: E2f1 (E2F transcription factor 1) Rattus norvegicus
Symbol: E2f1
Name: E2F transcription factor 1
RGD ID: 728892
Description: Enables protein kinase binding activity and sequence-specific DNA binding activity. Involved in several processes, including cellular response to hypoxia; cellular response to nerve growth factor stimulus; and positive regulation of glial cell proliferation. Located in nuclear chromosome. Biomarker of Huntington's disease and pancreatic cancer. Human ortholog(s) of this gene implicated in lung carcinoma (multiple); osteosarcoma; and pancreatic adenocarcinoma (multiple). Orthologous to human E2F1 (E2F transcription factor 1); PARTICIPATES IN cell cycle pathway, mitotic; ceramide signaling pathway; chronic myeloid leukemia pathway; INTERACTS WITH (-)-citrinin; (-)-epigallocatechin 3-gallate; 1-naphthyl isothiocyanate.
Type: protein-coding
Previously known as: E2F-1; transcription factor E2F1
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Is Marker For: Strains:   SD  
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.23143,064,535 - 143,075,362 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl3143,049,478 - 143,075,361 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx3146,931,136 - 146,941,990 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.03155,549,300 - 155,560,154 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.03153,288,668 - 153,299,512 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.03150,062,895 - 150,073,721 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl3150,047,826 - 150,073,721 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.03156,435,530 - 156,446,390 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.43145,032,489 - 145,043,729 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.13144,943,133 - 144,943,246 (-)NCBI
Celera3141,799,009 - 141,809,945 (-)NCBICelera
Cytogenetic Map3q41NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(-)-citrinin  (EXP)
(-)-epigallocatechin 3-gallate  (EXP)
(1->4)-beta-D-glucan  (ISO)
(25R)-cholest-5-ene-3beta,26-diol  (ISO)
(S)-colchicine  (ISO)
(S)-naringenin  (ISO)
(S)-nicotine  (ISO)
1,2-dimethylhydrazine  (ISO)
1-chloro-2,4-dinitrobenzene  (ISO)
1-methyltryptophan  (ISO)
1-naphthyl isothiocyanate  (EXP)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
17beta-hydroxy-5alpha-androstan-3-one  (ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
2-acetamidofluorene  (EXP)
26-hydroxycholesterol  (ISO)
3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid  (ISO)
3-aminobenzamide  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-hydroperoxycyclophosphamide  (ISO)
4-hydroxynon-2-enal  (ISO)
4-hydroxyphenyl retinamide  (ISO)
5-aza-2'-deoxycytidine  (ISO)
5-azacytidine  (ISO)
5-fluorouracil  (ISO)
5-nitroso-8-quinolinol  (ISO)
6-propyl-2-thiouracil  (EXP)
acetamide  (EXP)
acetylsalicylic acid  (ISO)
acrylamide  (ISO)
acteoside  (ISO)
adenine  (ISO)
aflatoxin B1  (EXP,ISO)
all-trans-4-oxoretinoic acid  (ISO)
all-trans-retinoic acid  (ISO)
alpha-hexylcinnamaldehyde  (ISO)
alvocidib  (ISO)
amitrole  (EXP)
ammonium chloride  (EXP)
amodiaquine  (ISO)
amphetamine  (EXP)
amphibole asbestos  (ISO)
androstane  (ISO)
aristolochic acid A  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenous acid  (ISO)
aspartame  (ISO)
Aspidin  (ISO)
atrazine  (ISO)
auraptene  (ISO)
azoxystrobin  (ISO)
benzo[a]pyrene  (ISO)
benzo[a]pyrene diol epoxide I  (ISO)
benzo[d]isothiazol-3-one  (ISO)
benzophenanthridine  (ISO)
biotin  (ISO)
bis(2-chloroethyl) sulfide  (ISO)
bisphenol A  (EXP,ISO)
bortezomib  (ISO)
Butylparaben  (ISO)
cadmium atom  (EXP,ISO)
cadmium dichloride  (EXP,ISO)
caffeine  (ISO)
calcitriol  (ISO)
camptothecin  (ISO)
cannabidiol  (ISO)
capsaicin  (ISO)
carbamazepine  (ISO)
carbon nanotube  (ISO)
Cardanol  (ISO)
carmustine  (ISO)
chlorpromazine  (ISO)
chlorpyrifos  (ISO)
choline  (EXP,ISO)
chromium(6+)  (ISO)
cilostazol  (ISO)
cisplatin  (ISO)
cobalt atom  (EXP)
copper atom  (EXP,ISO)
copper(0)  (EXP,ISO)
copper(II) sulfate  (ISO)
cordycepin  (ISO)
coumestrol  (ISO)
curcumin  (EXP)
deguelin  (ISO)
diarsenic trioxide  (ISO)
dibenzo[a,l]pyrene  (ISO)
diclofenac  (ISO)
dieldrin  (EXP)
diethanolamine  (EXP,ISO)
dihydroxyacetone  (ISO)
dioxygen  (ISO)
doxorubicin  (ISO)
elemental selenium  (ISO)
endosulfan  (ISO)
etoposide  (ISO)
eugenol  (ISO)
folic acid  (ISO)
fulvestrant  (ISO)
furan  (EXP)
gamma-tocopherol  (ISO)
gefitinib  (ISO)
gentamycin  (EXP)
geraniol  (ISO)
glyphosate  (ISO)
GW 3965  (ISO)
harmine  (ISO)
heparin  (ISO)
hydroquinone  (ISO)
hydroxyurea  (ISO)
Indeno[1,2,3-cd]pyrene  (ISO)
indirubin  (ISO)
inulin  (ISO)
iron atom  (EXP)
iron(0)  (EXP)
L-methionine  (ISO)
Lasiocarpine  (ISO)
lead nitrate  (ISO)
leptomycin B  (ISO)
lidocaine  (ISO)
lipopolysaccharide  (ISO)
LY294002  (ISO)
maneb  (ISO)
melatonin  (ISO)
menadione  (ISO)
methimazole  (EXP)
methotrexate  (ISO)
methylseleninic acid  (ISO)
mifepristone  (ISO)
mitomycin C  (ISO)
monocrotaline  (ISO)
monosodium L-glutamate  (ISO)
motexafin gadolinium  (ISO)
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine  (ISO)
N-acetyl-L-cysteine  (ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (ISO)
N-methyl-N'-nitro-N-nitrosoguanidine  (ISO)
N-nitrosodiethylamine  (ISO)
nickel atom  (EXP)
nickel dichloride  (EXP,ISO)
niclosamide  (ISO)
nicotine  (ISO)
Nonylphenol  (ISO)
ochratoxin A  (ISO)
oleic acid  (ISO)
ozone  (ISO)
p-menthan-3-ol  (ISO)
paclitaxel  (EXP,ISO)
palbociclib  (ISO)
paracetamol  (EXP,ISO)
paraquat  (EXP,ISO)
parathion  (ISO)
pentachlorophenol  (EXP)
perfluorooctane-1-sulfonic acid  (ISO)
phenobarbital  (ISO)
phenytoin  (ISO)
phosphoramide mustard  (EXP)
phthalaldehyde  (ISO)
piperonyl butoxide  (ISO)
pirinixic acid  (ISO)
plumbagin  (ISO)
pregnenolone 16alpha-carbonitrile  (ISO)
progesterone  (ISO)
propylparaben  (ISO)
PX-866  (ISO)
quercetin  (ISO)
quinoline  (ISO)
raloxifene  (ISO)
resveratrol  (ISO)
riddelliine  (ISO)
rifampicin  (ISO)
ritonavir  (ISO)
royal jelly  (EXP)
selenium atom  (ISO)
silicon dioxide  (ISO)
silver(1+) nitrate  (ISO)
simvastatin  (ISO)
sirolimus  (ISO)
sodium arsenite  (ISO)
sulfadimethoxine  (EXP)
sulforaphane  (ISO)
sulindac  (ISO)
tamoxifen  (EXP,ISO)
tauroursodeoxycholic acid  (EXP)
tert-butyl hydroperoxide  (ISO)
testosterone  (ISO)
tetrachloromethane  (ISO)
thapsigargin  (ISO)
thioacetamide  (EXP)
tocopherol  (ISO)
toluene 2,4-diisocyanate  (ISO)
trabectedin  (ISO)
trimellitic anhydride  (ISO)
Triptolide  (EXP)
troglitazone  (ISO)
trovafloxacin  (ISO)
tungsten  (EXP)
tunicamycin  (ISO)
urethane  (ISO)
ursodeoxycholic acid  (EXP)
valproic acid  (ISO)
vemurafenib  (ISO)
vincaleukoblastine  (ISO)
vinyl carbamate  (ISO)
wortmannin  (ISO)
zinc acetate  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process

Cellular Component


References - curated
# Reference Title Reference Citation
1. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. Alonso MM, etal., J Natl Cancer Inst. 2005 Nov 2;97(21):1589-600. doi: 10.1093/jnci/dji340.
2. Gamma-linolenic acid alters Ku80, E2F1, and bax expression and induces micronucleus formation in C6 glioma cells in vitro. Benadiba M, etal., IUBMB Life. 2009 Mar;61(3):244-51.
3. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression. Chen L, etal., J Biol Chem. 2013 May 17;288(20):14510-21. doi: 10.1074/jbc.M113.458737. Epub 2013 Mar 29.
4. The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: An in vivo and in vitro study. Chen S, etal., Int J Biol Macromol. 2017 Sep;102:718-728. doi: 10.1016/j.ijbiomac.2017.03.123. Epub 2017 Mar 23.
5. Gene expression profile of circulating CD34(+) cells and granulocytes in chronic myeloid leukemia. Cokic VP, etal., Blood Cells Mol Dis. 2015 Dec;55(4):373-81. doi: 10.1016/j.bcmd.2015.08.002. Epub 2015 Aug 7.
6. Knockdown of E2f1 by RNA interference impairs proliferation of rat cells in vitro. Dos Reis Vasques L, etal., Genet Mol Biol. 2010 Jan;33(1):17-22. doi: 10.1590/S1415-47572009005000104. Epub 2010 Mar 1.
7. Differential expression of members of the E2F family of transcription factors in rodent testes. El-Darwish KS, etal., Reprod Biol Endocrinol. 2006 Dec 5;4:63.
8. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Eymin B, etal., Oncogene. 2001 Mar 29;20(14):1678-87. doi: 10.1038/sj.onc.1204242.
9. Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1 (-/- )mice. Fajas L, etal., J Clin Invest 2004 May;113(9):1288-95.
10. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Field SJ, etal., Cell 1996 May 17;85(4):549-61.
11. Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cells. Fujita N, etal., Am J Physiol Heart Circ Physiol 2002 Jul;283(1):H204-12.
12. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
13. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
14. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. Gorgoulis VG, etal., J Pathol. 2002 Oct;198(2):142-56. doi: 10.1002/path.1121.
15. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice. Iglesias A, etal., J Clin Invest 2004 May;113(10):1398-407.
16. The transcriptional co-regulator HCF-1 is required for INS-1 β-cell glucose-stimulated insulin secretion. Iwata TN, etal., PLoS One. 2013 Nov 8;8(11):e78841. doi: 10.1371/journal.pone.0078841. eCollection 2013.
17. Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. Jordan-Sciutto KL, etal., J Neuropathol Exp Neurol. 2002 Apr;61(4):358-67.
18. Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis. Jordan-Sciutto KL, etal., J Neurosci. 2002 Mar 15;22(6):2185-95.
19. Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis. Kuhn H, etal., Eur Respir J. 2002 Sep;20(3):703-9.
20. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. Lee JS, etal., J Clin Oncol. 2010 Jun 1;28(16):2660-7. doi: 10.1200/JCO.2009.25.0977. Epub 2010 Apr 26.
21. Ribosomal protein S3, a new substrate of Akt, serves as a signal mediator between neuronal apoptosis and DNA repair. Lee SB, etal., J Biol Chem. 2010 Sep 17;285(38):29457-68. doi: 10.1074/jbc.M110.131367. Epub 2010 Jul 6.
22. Tumour growth-suppressive effect of arsenic trioxide in squamous cell lung carcinoma. Leung LL, etal., Oncol Lett. 2017 Sep;14(3):3748-3754. doi: 10.3892/ol.2017.6646. Epub 2017 Jul 21.
23. Differential regulation of MMPs by E2F1, Sp1 and NF-kappa B controls the small cell lung cancer invasive phenotype. Li Z, etal., BMC Cancer. 2014 Apr 22;14:276. doi: 10.1186/1471-2407-14-276.
24. TRIM28 knockdown increases sensitivity to etoposide by upregulating E2F1 in non-small cell lung cancer. Liu L, etal., Oncol Rep. 2017 Jun;37(6):3597-3605. doi: 10.3892/or.2017.5638. Epub 2017 May 11.
25. Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Loukopoulos P, etal., Cancer Sci. 2007 Mar;98(3):392-400. doi: 10.1111/j.1349-7006.2007.00395.x. Epub 2007 Jan 12.
26. The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma. Ma L, etal., Cancer Biol Ther. 2016 Oct 2;17(10):1051-1061. doi: 10.1080/15384047.2016.1219814. Epub 2016 Aug 29.
27. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
28. Up-regulation of E2F-1 in Down's syndrome brain exhibiting neuropathological features of Alzheimer-type dementia. Motonaga K, etal., Brain Res. 2001 Jun 29;905(1-2):250-3.
29. Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid. Pelegri C, etal., Int J Dev Neurosci. 2008 Nov;26(7):665-71. Epub 2008 Aug 12.
30. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
31. GOA pipeline RGD automated data pipeline
32. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
33. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
34. Antagonism of E2F-1 regulated Bnip3 transcription by NF-kappaB is essential for basal cell survival. Shaw J, etal., Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20734-9. Epub 2008 Dec 16.
35. E2F1 silencing inhibits migration and invasion of osteosarcoma cells via regulating DDR1 expression. Wang Z, etal., Int J Oncol. 2017 Dec;51(6):1639-1650. doi: 10.3892/ijo.2017.4165. Epub 2017 Oct 16.
36. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability. Woitach JT, etal., Nat Genet 1998 Aug;19(4):371-4.
37. Gene expression profiling of lung adenocarcinoma in Xuanwei, China. Wu H, etal., Eur J Cancer Prev. 2016 Nov;25(6):508-17. doi: 10.1097/CEJ.0000000000000214.
38. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). Xia G, etal., J Exp Clin Cancer Res. 2017 Aug 10;36(1):107. doi: 10.1186/s13046-017-0579-0.
39. Chromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3ß-E2F1 Axis Linking Reversely with Survival in Gliomas. Xiao D, etal., Theranostics. 2017 Jan 1;7(1):132-143. doi: 10.7150/thno.17032. eCollection 2017.
40. Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer. Xie X, etal., Cancer Biol Ther. 2013 Aug;14(8):742-51. doi: 10.4161/cbt.25184. Epub 2013 Jun 3.
41. Tumor induction and tissue atrophy in mice lacking E2F-1. Yamasaki L, etal., Cell 1996 May 17;85(4):537-48.
42. Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: an immunohistochemical study. Yamazaki K, etal., Pathol Res Pract. 2003;199(1):23-8. doi: 10.1078/0344-0338-00348.
43. The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes. Yurkova N, etal., Circ Res. 2008 Feb 29;102(4):472-9. Epub 2007 Dec 20.
44. The association of GSK3 beta with E2F1 facilitates nerve growth factor-induced neural cell differentiation. Zhou F, et al., J Biol Chem. 2008 May 23;283(21):14506-15. doi: 10.1074/jbc.M706136200. Epub 2008 Mar 26.
Additional References at PubMed
PMID:3951992   PMID:7797074   PMID:8673024   PMID:8918469   PMID:10082561   PMID:10597240   PMID:10779331   PMID:11004506   PMID:11071387   PMID:11095619   PMID:11331592   PMID:11418595  
PMID:11672531   PMID:12007404   PMID:12717439   PMID:12893818   PMID:14514686   PMID:14593116   PMID:14667810   PMID:15073182   PMID:15158336   PMID:15525772   PMID:15565177   PMID:15722552  
PMID:15731768   PMID:15735762   PMID:15766563   PMID:15990448   PMID:16360038   PMID:16717102   PMID:17062573   PMID:17102628   PMID:17404573   PMID:17482685   PMID:17555552   PMID:17989570  
PMID:18348166   PMID:18364697   PMID:18541936   PMID:18818403   PMID:19545562   PMID:20040599   PMID:20176812   PMID:20224733   PMID:20299467   PMID:21454377   PMID:21614651   PMID:21641965  
PMID:21937878   PMID:21964190   PMID:22476863   PMID:22592528   PMID:22848730   PMID:23332764   PMID:23629655   PMID:24014029   PMID:24453336   PMID:24726645   PMID:26306672   PMID:28125090  
PMID:29936143   PMID:34342400   PMID:35457270   PMID:36111777   PMID:37403456  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.23143,064,535 - 143,075,362 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl3143,049,478 - 143,075,361 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx3146,931,136 - 146,941,990 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.03155,549,300 - 155,560,154 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.03153,288,668 - 153,299,512 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.03150,062,895 - 150,073,721 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl3150,047,826 - 150,073,721 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.03156,435,530 - 156,446,390 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.43145,032,489 - 145,043,729 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.13144,943,133 - 144,943,246 (-)NCBI
Celera3141,799,009 - 141,809,945 (-)NCBICelera
Cytogenetic Map3q41NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh382033,675,477 - 33,686,385 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl2033,675,477 - 33,686,385 (-)EnsemblGRCh38hg38GRCh38
GRCh372032,263,283 - 32,274,191 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 362031,727,150 - 31,737,854 (-)NCBINCBI36Build 36hg18NCBI36
Build 342031,727,149 - 31,737,854NCBI
Celera2029,016,324 - 29,027,242 (-)NCBICelera
Cytogenetic Map20q11.22NCBI
HuRef2029,049,266 - 29,060,184 (-)NCBIHuRef
CHM1_12032,164,384 - 32,175,302 (-)NCBICHM1_1
T2T-CHM13v2.02035,402,008 - 35,412,916 (-)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm392154,401,320 - 154,411,812 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl2154,401,327 - 154,411,812 (-)EnsemblGRCm39 Ensembl
GRCm382154,559,400 - 154,569,892 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl2154,559,407 - 154,569,892 (-)EnsemblGRCm38mm10GRCm38
MGSCv372154,385,375 - 154,395,588 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv362154,251,080 - 154,261,293 (-)NCBIMGSCv36mm8
Celera2160,474,227 - 160,486,251 (-)NCBICelera
Cytogenetic Map2H1NCBI
cM Map276.79NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_00495542227,633,827 - 27,642,241 (+)EnsemblChiLan1.0
ChiLan1.0NW_00495542227,638,625 - 27,643,261 (+)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan12039,359,755 - 39,370,541 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v02029,963,083 - 29,973,860 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.12031,103,764 - 31,115,211 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl2031,103,764 - 31,110,604 (-)Ensemblpanpan1.1panPan2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.12422,895,149 - 22,904,689 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl2422,878,402 - 22,904,656 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha2422,540,395 - 22,549,906 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.02423,581,877 - 23,591,392 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl2423,581,862 - 23,616,878 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.12422,874,367 - 22,883,878 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.02422,967,923 - 22,977,434 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.02423,399,012 - 23,408,523 (-)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_024408640171,848,495 - 171,859,005 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365616,896,063 - 6,900,026 (+)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_0049365616,894,827 - 6,901,058 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl1737,178,599 - 37,189,883 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11737,178,587 - 37,190,118 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21742,116,195 - 42,125,518 (-)NCBISscrofa10.2Sscrofa10.2susScr3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.1237,968,541 - 37,980,461 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl237,968,556 - 37,980,326 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366605088,901,404 - 88,913,369 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla_female_1.0 EnsemblNW_0046248425,602,432 - 5,612,951 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046248425,602,432 - 5,612,951 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in E2f1
12 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:216
Count of miRNA genes:137
Interacting mature miRNAs:168
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
70216Cm14Cardiac mass QTL 142.1heart mass (VT:0007028)heart wet weight (CMO:0000069)331172320163586636Rat
2301970Bw81Body weight QTL 815.19body mass (VT:0001259)body weight (CMO:0000012)341874578155617519Rat
2301971Cm71Cardiac mass QTL 714.63heart left ventricle mass (VT:0007031)heart left ventricle weight (CMO:0000776)341874578155617519Rat
1559282Emca5Estrogen-induced mammary cancer QTL 53.9mammary gland integrity trait (VT:0010552)percentage of study population developing mammary tumors during a period of time (CMO:0000948)343827364169034231Rat
2292591Esta4Estrogen-induced thymic atrophy QTL 4thymus mass (VT:0004954)thymus wet weight (CMO:0000855)347233211147415807Rat
1581568Rf53Renal function QTL 53urine total protein amount (VT:0000032)urine protein excretion rate to body weight ratio (CMO:0001099)356395968161299569Rat
8662816Vetf4Vascular elastic tissue fragility QTL 44renal artery integrity trait (VT:0010642)number of ruptures of the internal elastic lamina of the renal arteries (CMO:0002563)359242096157323038Rat
1581546Pur13Proteinuria QTL 132.930.0335urine total protein amount (VT:0000032)urine protein excretion rate (CMO:0000759)378196190146592722Rat
631841Niddm39Non-insulin dependent diabetes mellitus QTL 393.36blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)394856903159898684Rat
2293087Iddm27Insulin dependent diabetes mellitus QTL 272.68blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)397551417147415807Rat
2312659Slep7Serum leptin concentration QTL 70.001blood leptin amount (VT:0005667)serum leptin level (CMO:0000780)398535255168026850Rat
2312670Bw94Body weight QTL 940.01inguinal fat pad mass (VT:0010424)inguinal fat pad weight to body weight ratio (CMO:0001253)398535255168026850Rat
2312673Scl63Serum cholesterol level QTL 630.001blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)398535255168026850Rat
2302373Gluco39Glucose level QTL 395.01blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)398535386161695835Rat
619618Rf3Renal disease susceptibility QTL 36.50.001urine albumin amount (VT:0002871)urine albumin excretion rate to body weight ratio (CMO:0001270)3107693393152693393Rat
1578754Stresp16Stress response QTL 1640.001blood renin amount (VT:0003349)plasma renin activity level (CMO:0000116)3112681431157681431Rat
1576306Schws3Schwannoma susceptibility QTL 30.001nervous system integrity trait (VT:0010566)percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017)3118839124163839124Rat
1598877Bp285Blood pressure QTL 2851.50.03arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)3120538241165538241Rat
1300173Rf11Renal function QTL 113.38renal blood flow trait (VT:2000006)absolute change in renal blood flow rate (CMO:0001168)3121056165145956249Rat
1300159Kidm4Kidney mass QTL 43.83kidney mass (VT:0002707)right kidney wet weight to body weight ratio (CMO:0001953)3121056165157309487Rat
10755461Coatc16Coat color QTL 16coat/hair pigmentation trait (VT:0010463)pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812)3122438700167438700Rat
631541Bp81Blood pressure QTL 814arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)3124122556169034231Rat
2303620Vencon4Ventilatory control QTL 43.9respiration trait (VT:0001943)tidal volume (CMO:0000222)3127162703168026850Rat
631673Iddm13Insulin dependent diabetes mellitus QTL 131.30.663blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)3130193298161695983Rat
1578656Vnigr2Vascular neointimal growth QTL 24.2artery morphology trait (VT:0002191)lesioned artery residual lumen area (CMO:0001417)3130656562169034231Rat
1578653Vnigr3Vascular neointimal growth QTL 33.1artery morphology trait (VT:0002191)artery neointimal hyperplastic lesion area (CMO:0001414)3130656562169034231Rat
9589106Insul23Insulin level QTL 2313.860.001blood insulin amount (VT:0001560)plasma insulin level (CMO:0000342)3131635904169034231Rat
2298477Eau4Experimental allergic uveoretinitis QTL 40.0011uvea integrity trait (VT:0010551)experimental autoimmune uveitis score (CMO:0001504)3137398739169034231Rat
8552952Pigfal13Plasma insulin-like growth factor 1 level QTL 13blood insulin-like growth factor amount (VT:0010479)plasma insulin-like growth factor 1 level (CMO:0001299)3138799500169034231Rat
5686842Rf59Renal function QTL 59urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)3140069424146976080Rat
1298068Bp167Blood pressure QTL 1670.004arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)3141074471169034231Rat
1331726Bp208Blood pressure QTL 2083.129arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)3141339013162184794Rat
61335Bp20Blood pressure QTL 203arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)3141339236155617360Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.23143,087,759 - 143,087,884 (+)MAPPERmRatBN7.2
Rnor_6.03150,086,036 - 150,086,160NCBIRnor6.0
Rnor_5.03156,458,570 - 156,458,694UniSTSRnor5.0
RGSC_v3.43145,055,522 - 145,055,647RGDRGSC3.4
RGSC_v3.43145,055,523 - 145,055,647UniSTSRGSC3.4
RGSC_v3.15151,483,686 - 151,484,060RGD
Celera3141,820,568 - 141,820,692UniSTS
SHRSP x BN Map367.6099UniSTS
SHRSP x BN Map367.6099RGD
FHH x ACI Map384.7199RGD
Cytogenetic Map3q41UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.23143,068,189 - 143,068,402 (+)MAPPERmRatBN7.2
Rnor_6.03150,066,550 - 150,066,762NCBIRnor6.0
Rnor_5.03156,439,185 - 156,439,397UniSTSRnor5.0
RGSC_v3.43145,036,144 - 145,036,356UniSTSRGSC3.4
Celera3141,802,800 - 141,803,012UniSTS
Cytogenetic Map3q41UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.23143,075,010 - 143,075,096 (+)MAPPERmRatBN7.2
Rnor_6.03150,073,371 - 150,073,456NCBIRnor6.0
Rnor_5.03156,446,040 - 156,446,125UniSTSRnor5.0
RGSC_v3.43145,043,379 - 145,043,464UniSTSRGSC3.4
Celera3141,809,595 - 141,809,680UniSTS
Cytogenetic Map3q41UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.23143,075,205 - 143,075,286 (+)MAPPERmRatBN7.2
Rnor_6.03150,073,566 - 150,073,646NCBIRnor6.0
Rnor_5.03156,446,235 - 156,446,315UniSTSRnor5.0
RGSC_v3.43145,043,574 - 145,043,654UniSTSRGSC3.4
Celera3141,809,790 - 141,809,870UniSTS
Cytogenetic Map3q41UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.23143,065,743 - 143,066,412 (+)MAPPERmRatBN7.2
Rnor_6.03150,064,104 - 150,064,772NCBIRnor6.0
Rnor_5.03156,436,739 - 156,437,407UniSTSRnor5.0
RGSC_v3.43145,033,698 - 145,034,366UniSTSRGSC3.4
Celera3141,800,218 - 141,800,886UniSTS
Cytogenetic Map3q41UniSTS

Related Rat Strains
The following Strains have been annotated to E2f1


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
Medium 1 26 12 6 7 6 65 18 35
Low 2 17 42 32 12 32 7 10 9 17 6 11 7
Below cutoff 3 3 3 1 1 1


RefSeq Acc Id: ENSRNOT00000022115   ⟹   ENSRNOP00000022115
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl3143,049,478 - 143,063,951 (-)Ensembl
Rnor_6.0 Ensembl3150,047,826 - 150,062,311 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000022428   ⟹   ENSRNOP00000022428
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl3143,049,478 - 143,075,361 (-)Ensembl
Rnor_6.0 Ensembl3150,062,895 - 150,073,721 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000086933   ⟹   ENSRNOP00000070039
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl3143,049,478 - 143,063,951 (-)Ensembl
Rnor_6.0 Ensembl3150,048,341 - 150,064,438 (-)Ensembl
RefSeq Acc Id: NM_001100778   ⟹   NP_001094248
Rat AssemblyChrPosition (strand)Source
mRatBN7.23143,064,535 - 143,075,361 (-)NCBI
Rnor_6.03150,062,895 - 150,073,721 (-)NCBI
Rnor_5.03156,435,530 - 156,446,390 (-)NCBI
RGSC_v3.43145,032,489 - 145,043,729 (-)RGD
Celera3141,799,009 - 141,809,945 (-)RGD
RefSeq Acc Id: XM_039105617   ⟹   XP_038961545
Rat AssemblyChrPosition (strand)Source
mRatBN7.23143,065,806 - 143,075,362 (-)NCBI
RefSeq Acc Id: XM_039105618   ⟹   XP_038961546
Rat AssemblyChrPosition (strand)Source
mRatBN7.23143,064,535 - 143,074,378 (-)NCBI
RefSeq Acc Id: NP_001094248   ⟸   NM_001100778
- UniProtKB: O09139 (UniProtKB/Swiss-Prot),   A6KHZ9 (UniProtKB/TrEMBL),   A0A8L2QBV4 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000022428   ⟸   ENSRNOT00000022428
RefSeq Acc Id: ENSRNOP00000022115   ⟸   ENSRNOT00000022115
RefSeq Acc Id: ENSRNOP00000070039   ⟸   ENSRNOT00000086933
RefSeq Acc Id: XP_038961546   ⟸   XM_039105618
- Peptide Label: isoform X2
RefSeq Acc Id: XP_038961545   ⟸   XM_039105617
- Peptide Label: isoform X1
Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-O09139-F1-model_v2 AlphaFold O09139 1-432 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

RGD ID:13692575
Promoter ID:EPDNEW_R3100
Type:single initiation site
Description:E2F transcription factor 1
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Rat AssemblyChrPosition (strand)Source
Rnor_6.03150,073,687 - 150,073,747EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:728892 AgrOrtholog
BioCyc Gene G2FUF-47169 BioCyc
Ensembl Genes ENSRNOG00000016708 Ensembl, ENTREZGENE, UniProtKB/TrEMBL
  ENSRNOG00055026928 UniProtKB/Swiss-Prot
  ENSRNOG00060024587 UniProtKB/Swiss-Prot
  ENSRNOG00065025204 UniProtKB/Swiss-Prot
Ensembl Transcript ENSRNOT00000022428 ENTREZGENE
  ENSRNOT00000022428.7 UniProtKB/TrEMBL
  ENSRNOT00000086933.2 UniProtKB/TrEMBL
  ENSRNOT00055046483 UniProtKB/Swiss-Prot
  ENSRNOT00060042569 UniProtKB/Swiss-Prot
  ENSRNOT00065043397 UniProtKB/Swiss-Prot
Gene3D-CATH UniProtKB/Swiss-Prot, UniProtKB/TrEMBL UniProtKB/TrEMBL UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EF-hand UniProtKB/TrEMBL
InterPro ABM_dom UniProtKB/TrEMBL
  Dimeric_a/b-barrel UniProtKB/TrEMBL
  E2F UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  E2F-DP_heterodim UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  E2F_CC-MB UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  E2F_WHTH_DNA-bd_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EF-hand-dom_pair UniProtKB/TrEMBL
  EF_Hand_1_Ca_BS UniProtKB/TrEMBL
  EF_hand_dom UniProtKB/TrEMBL
  NECAB1/2/3 UniProtKB/TrEMBL
  WH-like_DNA-bd_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  WH_DNA-bd_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:399489 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTHR12081 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTHR12178 UniProtKB/TrEMBL
  E2F_CC-MB UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  E2F_TDP UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EF-hand_5 UniProtKB/TrEMBL
PhenoGen E2f1 PhenoGen
RatGTEx ENSRNOG00000016708 RatGTEx
  ENSRNOG00055026928 RatGTEx
  ENSRNOG00060024587 RatGTEx
  ENSRNOG00065025204 RatGTEx
SMART E2F_TDP UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  EFh UniProtKB/TrEMBL
Superfamily-SCOP SSF144074 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  SSF46785 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  SSF47473 UniProtKB/TrEMBL
  SSF54909 UniProtKB/TrEMBL
  E2F1_RAT UniProtKB/Swiss-Prot, ENTREZGENE

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2004-12-14 E2f1  E2F transcription factor 1      Symbol and Name status set to approved 1299863 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_disease associated with atherosclerosis, hypertension, and restenosis after injury 625751
gene_expression expressed in vascular smooth muscle cells, fibroblasts and Saos-2 cell line 625751
gene_function transcription factor 625751
gene_process controls G1/S transition of eukaryotic cells by monitoring the regulation of transcription of growth-related genes 625751
gene_process involved in induction of S phase progression in quiescent cells 625751
gene_product member of transcriptional factor family 625751
gene_regulation RNA expression levels were downregulated in quiescent cells 625751
gene_regulation fetal bovine serum [FBS] induced upregulation of E2f1 mRNA and protein levels by inducing free E2f1 binding onto its promoter 625751